Cardiomyopathies
170
43
51
62
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
16 trials with published results (9%)
Research Maturity
62 completed trials (36% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.5%
6 terminated out of 170 trials
91.2%
+4.7% vs benchmark
11%
19 trials in Phase 3/4
26%
16 of 62 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 62 completed trials
Clinical Trials (170)
Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
The Heart Hive - Cardiomyopathy Study
RHYthm and Myocardial Function Relationship Evaluation in Heart Diseases
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
Sepsis in the ICU-II
PPG to Predict Ejection Fraction and Other Echographic Data in the General Population
PKP2-ACM Natural History Study
Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease
Edema and Fibrosis CMR Imaging in Cardiomyopathy
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Multimodal Analysis of Endomyocardial Biopsies
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
Observational Study to Validate a Family Physician Echocardiography Training Programme
SMCs With LVH Compared to HCM
Towards Understanding the Phenotype of Cardiovascular Disease in CKD - TRUE-Type-CKD Study
International T1 Multicenter Outcome Study
AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)
High Intensity His Bundle Pacing in Heart Failure Patients With Narrow QRS Outcome Study
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion